Inter-university Service of Preventive Medicine and Promotion of Health (SIMPPS), University Paul Sabatier, Toulouse, France.
Eur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):186-90. doi: 10.1016/j.ejogrb.2009.10.024. Epub 2009 Nov 18.
In France, human papillomavirus (HPV) vaccine is routinely recommended for 14-year-old girls; a catch-up vaccination should be offered to girls and women 15-23 years of age before the first time they have sex or within the first year after sexual activity begins. The aim of the present study was to examine the eligibility and willingness of first-year college students of Toulouse University (France) to participate in a HPV vaccination catch-up program, and to estimate their knowledge of HPV vaccination and cervical cancer screening.
The study was conducted from January to April 2008 simultaneously at the three university medical centres (Science, Literature-Psychology, Law-Social Sciences). Female students entering the University were asked to complete an anonymous questionnaire at the time of their preventive medical visit. The questionnaire included questions on demographics, knowledge about HPV vaccination, sexual behaviour, and willingness to participate in the French vaccination program.
In total, 606 women from the 3 colleges were included. The response rate of the questionnaire was 93.1%. The median age of participants was 19 and 8.3% of them had already been vaccinated. Of the respondents, 67.2% were sexually experienced and 25.3% of sexually experienced students had their first intercourse less than 1 year prior. Knowledge of HPV infections, associated diseases, and prevention was limited, a finding that indicates the need to pursue educational campaigns. Among respondents, 42.7% were eligible for catch-up vaccination, and 64.1% of them were willing to be vaccinated. We did not observe significant differences among the three colleges.
First-year college preventive consultation is an opportunity to vaccinate near 43% of women according to French recommendations. Improved education about HPV-related diseases and their prevention is needed.
在法国，人乳头瘤病毒（HPV）疫苗被常规推荐用于 14 岁的女孩；对于 15-23 岁的女孩和妇女，应在首次性行为之前或性行为开始后的第一年提供补种疫苗。本研究的目的是调查图卢兹大学（法国）一年级女大学生参与 HPV 疫苗补种计划的资格和意愿，并评估她们对 HPV 疫苗接种和宫颈癌筛查的认识。
本研究于 2008 年 1 月至 4 月在三所大学医疗中心（科学、文学-心理学、法律-社会科学）同时进行。进入大学的女学生在进行预防医学检查时被要求填写一份匿名问卷。问卷包括人口统计学、HPV 疫苗接种知识、性行为以及参与法国疫苗接种计划的意愿等问题。
共纳入了来自 3 所学院的 606 名女性。问卷的回复率为 93.1%。参与者的中位年龄为 19 岁，其中 8.3%的人已经接种了疫苗。在应答者中，67.2%有过性经历，25.3%有性经历的学生首次性行为发生在 1 年前。对 HPV 感染、相关疾病和预防的了解有限，这表明需要开展教育宣传活动。在应答者中，42.7%符合补种疫苗的条件，其中 64.1%愿意接种疫苗。我们没有观察到三所学院之间存在显著差异。
根据法国的建议，一年级女大学生预防咨询为接种近 43%的女性提供了机会。需要加强有关 HPV 相关疾病及其预防的教育。
